2 Patents
- US123701952025Oral Compositions of MK2 Pathway Inhibitor for Treatment of Immune Conditions
Aclaris Therapeutics, Inc.
0 cites - US118448012023Oral Compositions of MK2 Pathway Inhibitor for Treatment of Immune Conditions
Aclaris Therapeutics, Inc.
0 cites